Stroke complicAtions After TraUmatic expeRieNces and Stress
NCT ID: NCT03496480
Last Updated: 2019-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
636 participants
OBSERVATIONAL
2018-04-15
2019-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Markers of Post-Stroke Depression (PROMoSD)
NCT05580198
Imaging and Serological Biomarkers of Autonomic Dysfunction After Ischemic Stroke
NCT06740942
Comparison of Pre-hospital and In-hospital Iv-tPA Stroke Treatment
NCT02358772
Endothelial Function and Progenitor Cells in Acute Ischemic Stroke
NCT01289795
Hemodynamic in Postreperfusion Period and Functional Recovery in Acute Ischemic Stroke Patients
NCT05517109
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For a period of 22 months, all stroke patients treated at the Charité Medical Center will be screened retrospectively 9-13 months after a first-ever ischemic stroke (\~2000). All eligible patients will be contacted by mail 9-13 months after their hospital stay with the request that they complete the questionnaires. The mailing will also include an information statement, the consent form, as well as a stamped return envelope.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaires
Psychological questionnaires: BTQ, IES-R, 7-items-short Screening scale, BDI, SF-36
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Confirmation of diagnosis by CT or MRI
3. Age \> 18 years
4. Ability to give informed consent
Exclusion Criteria
2. Major diseases at the time of the hospital stay that would be expected to obviate meaningful follow-up assessments such as life-threatening heart or respiratory failure, renal or hepatic failure, cancer
2\. Severe comprehension deficits, e.g. severe aphasia, dementia 3. Substantial pre-stroke disability (e.g. from a previous stroke)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johanna Schöner
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johanna Schöner
study doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charité Universitätsmedizin Berlin
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EA2/113/16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.